MultiCell Technologies (PK) Stock Price

0.00005 (100.0%)
Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
Ultimate Trader (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
MultiCell Technologies Inc (PK) MCET OTCMarkets Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Previous Close Last Traded
0.00005 100.0% 0.0001 0.0001 0.0001 0.0001 0.00005 16:33:02
Bid Price Ask Price Spread Spread % News
0.0001 0.0002 0.00 0.0% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
1 20,000 $ 0.0001 $ 2 1,924,525 0.000001 - 0.001
Last Trade Time Type Quantity Stock Price Currency
15:49:52 20,000 $ 0.0001 USD

MultiCell Technologies (PK) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 500.10k 5.00B 600.00k $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
2.31k $ - 0.00% - -

more financials information »

MultiCell Technologies (PK) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical MCET Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.00010.00010.000050.00007492,010,8570.000.0%
1 Month0.00010.00020.0000010.00007721,928,8120.000.0%
3 Months0.00010.00020.0000010.00008492,198,4840.000.0%
6 Months0.00010.0010.0000010.00009173,043,7080.000.0%
1 Year0.0000010.0010.0000010.00008053,335,4090.00019,900.0%
3 Years0.00010.0010.0000010.00011182,614,1420.000.0%
5 Years0.00030.0010.0000010.00018083,429,523-0.0002-66.67%

MultiCell Technologies (PK) Description

MultiCell Technologies, Inc. is a clinical-stage biopharmaceutical company developing novel therapeutics and discovery tools that address unmet medical needs for the treatment of neurological disorders, hepatic disease, fatigue of MS and cancer. The majority owned Xenogenics subsidiary is developing a drug-eluting cardiac stent.

Your Recent History
MultiCell ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.